Scientific work

Dr. Mehmet Teomete

32 publications. The source of the information is stated next to each publication.

Back to profile

  1. Abstract P4-11-03: Prediciting high risk hormone receptor (HR) positive Her-2 negative early breast cancer (BC) by artificial intelligence (AI) algorithms

    Clinical Cancer Research, 2025

    DOI 10.1158/1557-3265.sabcs24-p4-11-03 Source: OpenAlex

  2. Recommendations for cyclin‑dependent kinase 4/6 inhibitor treatments in the context of co‑morbidity and drug interactions (Review)

    Oncology Letters, 2024

    DOI 10.3892/ol.2024.14278 PMID 38385117 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours—results from a Turkish multi-centre study

    Japanese Journal of Clinical Oncology, 2024

    DOI 10.1093/jjco/hyae002 PMID 38271177 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  4. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy

    Journal of Oncology, 2020

    DOI 10.1155/2020/1360431 PMID 32670370 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. 2008P The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.1314 Open-access full textSource: OpenAlex

  6. Prognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz253.091 Source: OpenAlex

  7. Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e24306 Source: OpenAlex

  8. Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.1.117 PMID 24528011 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer.

    Europe PMC (PubMed Central), 2014

    PMID 24995112 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  10. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

    Journal of Clinical Oncology, 2012

    DOI 10.1200/jco.2012.30.15_suppl.e16015 Open-access full textSource: OpenAlex

  11. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

    Kocaeli Üniversitesi - AVESİS, 2012

    Source: OpenAlex

  12. Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study.

    PubMed, 2011

    PMID 21766495 Open-access full textSource: OpenAlex

  13. Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey

    Medical Oncology, 2010

    DOI 10.1007/s12032-010-9463-x PMID 20306160 17 citations (Europe PMC) Source: OpenAlex

  14. Pregnancy a short time after multimodal therapy for bilateral breast cancer: A case report and review of literature

    Journal of Oncology Pharmacy Practice, 2010

    DOI 10.1177/1078155210384755 PMID 20858636 2 citations (Europe PMC) Source: OpenAlex

  15. Weight gain after adjuvant chemotherapy in early breast cancer patients in Istanbul.

    Journal of Clinical Oncology, 2010

    DOI 10.1200/jco.2010.28.15_suppl.e11099 Source: OpenAlex

  16. A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin's lymphoma: the importance of second opinion.

    PubMed, 2009

    PMID 19650184 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  17. Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)

    Journal of Clinical Oncology, 2009

    DOI 10.1200/jco.2009.27.15_suppl.e19055 Open-access full textSource: OpenAlex

  18. Weight gain after adjuvant treatment in breast cancer patients in Istanbul, Turkey

    Journal of Clinical Oncology, 2009

    DOI 10.1200/jco.2009.27.15_suppl.e11620 Source: OpenAlex

  19. Pulmonary toxicity in patients receiving docetaxel chemotherapy

    Journal of Clinical Oncology, 2009

    DOI 10.1200/jco.2009.27.15_suppl.e13532 Open-access full textSource: OpenAlex

  20. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus

    Journal of Diabetes and its Complications, 2008

    DOI 10.1016/j.jdiacomp.2008.01.006 PMID 18358749 110 citations (Europe PMC) Source: OpenAlex

  21. Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience

    Journal of Clinical Oncology, 2008

    DOI 10.1200/jco.2008.26.15_suppl.15103 Source: OpenAlex

  22. Clinical outcome of triple-negative (TN) breast cancer (BC)

    Journal of Clinical Oncology, 2008

    DOI 10.1200/jco.2008.26.15_suppl.11526 Source: OpenAlex

  23. Benefit from adjuvant anthracyclines according to hormone receptor status

    Journal of Clinical Oncology, 2008

    DOI 10.1200/jco.2008.26.15_suppl.11513 Open-access full textSource: OpenAlex

  24. Outcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital

    Journal of Clinical Oncology, 2007

    DOI 10.1200/jco.2007.25.18_suppl.14588 Source: OpenAlex

  25. Clinical outcome of node-negative (NN) breast cancer (BC) patients

    Journal of Clinical Oncology, 2007

    DOI 10.1200/jco.2007.25.18_suppl.11102 Open-access full textSource: OpenAlex

  26. P2-323: Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

    Journal of Thoracic Oncology, 2007

    DOI 10.1097/01.jto.0000284031.87598.62 Open-access full textSource: OpenAlex

  27. Outcome of rectal carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital

    Journal of Clinical Oncology, 2006

    DOI 10.1200/jco.2006.24.18_suppl.13584 Source: OpenAlex

  28. Outcome of adjuvant treatment in turkish breast cancer (BC) patients (PTS): Single institution experience

    Kocaeli Üniversitesi - AVESİS, 2006

    Source: OpenAlex

  29. Outcome of metastatic colorectal cancer patients receiving palliative chemotherapy in Marmara University Hospital

    Kocaeli Üniversitesi - AVESİS, 2006

    Source: OpenAlex

  30. Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

    Kocaeli Üniversitesi - AVESİS, 2006

    Source: OpenAlex

  31. 0utcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital F. Dane, M. Gumus, A. Ozturk, F. Yumuk, S. Iyikesici, G. Basaran, D. Cabuk, M. Teomete and N. S. Turhal

    Source: acibadem.com.tr profile page

  32. 0utcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

    Source: acibadem.com.tr profile page